M
Mary Ruth Erickson
Publications - 10
Citations - 2116
Mary Ruth Erickson is an academic researcher. The author has contributed to research in topics: Nucleic acid & Energy homeostasis. The author has an hindex of 4, co-authored 10 publications receiving 2048 citations.
Papers
More filters
Journal ArticleDOI
Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice
Joachim Fruebis,Tsu-Shuen Tsao,Sandrine Javorschi,Dana Ebbets-Reed,Mary Ruth Erickson,Frances T. Yen,Bernard Bihain,Harvey F. Lodish +7 more
TL;DR: Daily administration of a very low dose of gAcrp30 to mice consuming a high-fat/sucrose diet caused profound and sustainable weight reduction without affecting food intake.
Patent
Obg3 globular head and uses thereof for decreasing body mass
TL;DR: A compound, globular OBG3, has been identified that reduces weight gain in animals as mentioned in this paper, which should be effective for reducing body mass and for treating obesity-related diseases and disorders.
Patent
Methods of screening for compounds that modulate the lsr-leptin interaction and their use in the prevention and treatment of obesity-related diseases
TL;DR: In this paper, the authors present methods of screening for new compounds for the treatment of obesity and obesity related diseases and disorders, as well as methods of treating obesity-related disorders, based on the discovery of the role of the leptin-LSR interaction in obesity.
Patent
OBG3 Globular Head and Uses Thereof
TL;DR: A compound, globular OBG3, has been identified that reduces weight gain in animals as discussed by the authors, which should be effective for reducing body mass and for treating obesity-related diseases and disorders.
Patent
Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof
Mary Ruth Erickson,Barbara A. Bour,Bernard Bihain,Hiroaki Tanaka,Tom Chu,Deno Dialynas,Aaron Scalia +6 more
TL;DR: In this paper, the authors proposed a method for reducing body mass and treating metabolic-related diseases and disorders, such as hyperlipidemias, atherosclerosis, diabetes, and hypertension.